Stella Diagnostics (Stella Diagnostics) ROCE % : 0.00% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Stella Diagnostics's annualized ROCE % for the quarter that ended in Sep. 2023 was 0.00%.

Stella Diagnostics ROCE % Historical Data

The historical data trend for Stella Diagnostics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics ROCE % Chart

Stella Diagnostics Annual Data

Trend

ROCE %

Stella Diagnostics Quarterly Data
	Sep22	Sep23
ROCE %	-	-

Stella Diagnostics ROCE % Calculation

Stella Diagnostics's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: . 20 )		(A: . 20 )		(A: . 20 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

Stella Diagnostics's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Sep. 2022 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Sep. 2022 )		(Q: Sep. 2023 )
	=	-3.108	/	( ( (0 - 0)	+	(0.441 - 16.065) )	/ 1 )
	=	-3.108	/	( ( 0	+	-15.624 )	/ 1 )
	=	-3.108	/	-15.624
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Stella Diagnostics (OTCPK:SLDX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Stella Diagnostics ROCE % Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.